US President Donald Trump announced new tariffs to protect domestic industry. Starting from October 1, branded medicines will face a 100 percent tariff, trucks 25 percent, and kitchen equipment and soft furniture 30–50 percent.
This decision caused instability in international markets. Shares of pharmaceutical companies fell on Asian stock markets. In Europe, after an initial decline, the market partially recovered.
Pharmaceutical companies that have not established production in the US may face significant losses. Ireland, however, took the new tariffs into account in advance and sharply increased its medicine exports to the US.
According to experts, the new tariffs may support the US domestic market, but there is a possibility of rising transport costs and consumer prices.
Read 'Zamin' on Telegram!